CAF-DCF is a Belgian company specialized in the commercialization of plasma derived medicines.
They have long term expertise in life-saving products for rare and life-threatening diseases in three therapeutic domains : immunology, intensive care and hemostasis.
Their driving values are:
The use of blood plasma drawn from volunteer donors and the preparation of products intended to save patients are the cornerstone of their "human-to-human approach".
CAF-DCF is controlled by the French biopharmaceutical group LFB. The company has historically been founded by the Belgian Red Cross and has a 40 years history of ethical product development , production and commercialization in the field of plasma derived medicines.
Samen vinden we de beste oplossing voor uw organisatie! Onze consultants staan klaar om u te helpen en nemen zo snel mogelijk contact met u op.